SI-BONE, Inc. Announces CFO Departure and Interim Appointment
Ticker: SIBN · Form: 8-K · Filed: 2024-08-05T00:00:00.000Z
Sentiment: neutral
Topics: cfo-departure, interim-appointment, financial-results
Related Tickers: SIBN
TL;DR
SI-BONE's CFO is out, interim CFO in. Financials also updated.
AI Summary
SI-BONE, Inc. announced on August 4, 2024, the departure of its Chief Financial Officer, Edward G. Kilroy, Jr., effective August 2, 2024. The company also announced the appointment of Michael J. Farrell as interim CFO. Additionally, the company reported its financial results for the period ending August 4, 2024, though specific figures were not detailed in this initial filing.
Why It Matters
The departure of a CFO can signal financial strategy shifts or internal challenges, while the appointment of an interim CFO suggests a transition period for financial leadership.
Risk Assessment
Risk Level: medium — A CFO departure and interim appointment can indicate underlying financial or strategic issues within the company.
Key Players & Entities
- SI-BONE, Inc. (company) — Registrant
- Edward G. Kilroy, Jr. (person) — Departing Chief Financial Officer
- August 4, 2024 (date) — Date of report
- August 2, 2024 (date) — Effective date of CFO departure
- Michael J. Farrell (person) — Interim Chief Financial Officer
FAQ
Who has been appointed as the interim Chief Financial Officer of SI-BONE, Inc.?
Michael J. Farrell has been appointed as the interim Chief Financial Officer of SI-BONE, Inc.
When was the departure of Edward G. Kilroy, Jr. as CFO effective?
The departure of Edward G. Kilroy, Jr. as CFO was effective August 2, 2024.
What is the exact name of the company filing this report?
The exact name of the company is SI-BONE, Inc.
What is the state of incorporation for SI-BONE, Inc.?
SI-BONE, Inc. is incorporated in Delaware.
What items are being reported in this 8-K filing?
This 8-K filing reports on Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, and Financial Statements and Exhibits.
Filing Stats: 968 words · 4 min read · ~3 pages · Grade level 10.3 · Accepted 2024-08-05 16:10:07
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share SIBN The Nasdaq Global Market
- $45,000 — policy: (1) an annual cash retainer of $45,000 for serving on the Board; (2) an initia
- $120,000 b — SU grant having an approximate value of $120,000 based on the 30-day trailing average of t
Filing Documents
- sibn-20240804.htm (8-K) — 34KB
- exhibit991_sibn6302024earn.htm (EX-99.1) — 113KB
- si-bonelogoa07a.jpg (GRAPHIC) — 31KB
- 0001459839-24-000061.txt ( ) — 317KB
- sibn-20240804.xsd (EX-101.SCH) — 2KB
- sibn-20240804_lab.xml (EX-101.LAB) — 21KB
- sibn-20240804_pre.xml (EX-101.PRE) — 12KB
- sibn-20240804_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 5, 2024, SI-BONE, Inc. (the "Company") issued a press release (the "Press Release") announcing results for the quarter ended June 30, 2024. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein. The information under Item 2.02 in this current report on Form 8-K and the related information in the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 4, 2024, the Company's board of directors ("Board") elected Daniel Wolf to serve as a director of the Company effective August 5, 2024, until his successor is elected and qualified, or sooner in the event of his death, resignation or removal. Mr. Wolf has served as Senior Vice President, Chief Strategy and M&A Officer at Baxter International Inc. since August 2022. From July 2010 to August 2022, Mr. Wolf served in various leadership positions with Medtronic plc, including President of Medicrea and Vice President and General Manager of Intelligent Data Solutions, as well as other roles in strategy, business development and healthcare economics, corporate development and national and strategic accounts. Mr. Wolf has also served on the boards of directors of HospitalIQ, Inc. from October 2022 to its acquisition by LeanTaaS, Inc. in January 2023, Blue Wind Medical Ltd. from July 2017 to December 2018, and Inspire Medical Systems, Inc. from July 2017 until its May 2018
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated August 5 , 2024 104 Cover Page Interactive Date File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SI-BONE, INC. Date: August 5, 2024 By: /s/ Anshul Maheshwari Anshul Maheshwari Chief Financial Officer (Principal Financial and Accounting Officer)